Earlybird heads for Growth Opportunities final close

Growth Opportunities Fund IV is expected to hold a final close on its hard-cap soon, the firm told Unquote. The fund was registered in September 2020 and is domiciled in Germany. The Growth Opportunities strategy will make later-stage follow-on investments in Earlybird's existing portfolio companies across its Digital West, Digital East and Health funds.

Earlybird Health II was registered in August 2020 and is expected to follow the strategy of the firm's first health-focused fund, focusing on investments in early-stage and later-stage digital health, medical devices diagnostics companies. The GP's first health fund held a final close in August 2018 on €85m and its investments include Switzerland-based diabetes management platform Oviva, as well as Belgium-based ophthalmic implant producer iStar Medical.

Earlybird's latest Digital West fund will also pursue the same strategy as its predecessor, targeting early-stage digital technology businesses based in western Europe. The fund's predecessor held a final close in July 2018 on €175m, surpassing its target of €150m. The strategy aims to support companies with their global expansion.

Earlybird also manages a Digital East strategy, through which it invests in startups based in CEE (excluding Russia) and Turkey. Its second fund in the strategy held a final close in February 2021 on €200m, surpassing its target of €150m.

Across its strategies, Earlybird makes investments of €500,000-10m. The firm was founded in 1997 has offices in Berlin and Munich.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Venture
• Fundraising
• DACH
• CEE
• Benelux
• Nordics
• France
• Germany
• Earlybird
• Venture
• Exclusive